Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy

ID#: NCT06313632

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: Phase 3

Recruitment Status: Recruiting

Start Date: March 13, 2024

End Date: March 01, 2025

Contact Information:
Udit Chaddha, MBBS
212-824-8546
Summary: PlAcebo versus erector spINae pLane block for mEdical ThoracoScopy Study (PAINLESS). This is a prospective triple-blind, randomized controlled trial that evaluates the efficacy of erector spinae plane block (ESPB) with Bupivacaine in reducing pain after medical thoracoscopy (MT) in addition to monitored anesthesia care vs monitored anesthesia care alone.
Eligibility:

Inclusion criteria:

- Referral for medical thoracoscopy

- Age ≥ 18

Exclusion criteria:

- Inability to provide informed consent.

- Study subject has any disease or condition that interferes with safe completion of the study including:

- Allergic reaction to Bupivacaine.

- Need for pleurodesis.

- Allergies to lidocaine or other local anesthetics.

- Pregnancy.

- Advanced liver disease where the clinician deems the procedure unsafe.
Find a Clinical Trial